-
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
(PA-18-001)
National Cancer Institute
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s): Multiple dates, see announcement.
-
Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)
(PA-18-002)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
(PA-18-003)
National Cancer Institute
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)
(PA-18-004)
National Cancer Institute
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)
(PA-18-005)
National Cancer Institute
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Optional)
(PA-18-010)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Heart, Lung, and Blood Institute
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional)
(PA-18-012)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
(PA-18-013)
National Cancer Institute
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)
(PA-18-014)
National Cancer Institute
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)
(PA-18-015)
National Cancer Institute
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)
(PA-18-025)
National Institute on Aging
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
(PA-18-031)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (R01 Clinical Trial Optional)
(PA-18-032)
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional)
(PA-18-033)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional)
(PA-18-034)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Studies at Periviable Gestation (R01 Clinical Trial Optional)
(PA-18-036)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
(PA-18-038)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
(PA-18-043)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
(PA-18-044)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
-
Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)
(PA-18-045)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional)
(PA-18-046)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Studies at Periviable Gestation (R03 Clinical Trial Optional)
(PA-18-053)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
(PA-18-055)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01 Clinical Trial Optional)
(PA-18-056)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
The Application of Big Data Analytics to Drug Abuse Research (R01 Clinical Trial Optional)
(PA-18-057)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Prescription Drug Abuse (R01 Clinical Trial Optional)
(PA-18-058)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
(PA-18-060)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional)
(PA-18-061)
National Institute on Drug Abuse
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
(PA-18-073)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional)
(PA-18-074)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
-
Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21 Clinical Trial Optional)
(PA-18-075)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Prescription Drug Abuse (R21 Clinical Trial Optional)
(PA-18-076)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
(PA-18-078)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional)
(PA-18-079)
National Institute on Drug Abuse
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional)
(PA-18-080)
National Institute on Drug Abuse
National Institute on Aging
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
(PA-18-092)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Studies at Periviable Gestation (R21 Clinical Trial Optional)
(PA-18-097)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
(PA-18-134)
National Institute of Nursing Research
National Institute on Aging
Application Receipt Date(s): Multiple receipt dates, see announcement.
-
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
(PA-18-135)
National Institute of Nursing Research
Office of Dietary Supplements
Application Receipt Date(s): Multiple dates, see announcement.
-
Functional Wellness in HIV: Maximizing the Treatment Cascade (R01 Clinical Trial Optional)
(PA-18-136)
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization
-
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
(PA-18-153)
National Institute of Nursing Research
National Institute on Aging
Application Receipt Date(s): Multiple receipt dates, see announcement.
-
Functional Wellness in HIV: Maximizing the Treatment Cascade (R21 Clinical Trial Optional)
(PA-18-154)
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.,Standard dates apply by 5:00 PM local time of applicant organization
-
Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01 Clinical Trial Optional)
(PA-18-191)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
(PA-18-260)
National Institute of Environmental Health Sciences
National Institute of Nursing Research
Application Receipt Date(s): September 7, 2019
-
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional)
(PA-18-284)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)
(PA-18-285)
National Institute on Minority Health and Health Disparities
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional)
(PA-18-287)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)
(PA-18-288)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed)
(PA-18-338)
Office of Behavioral and Social Sciences Research
National Heart, Lung, and Blood Institute
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional
(PA-18-339)
Office of Behavioral and Social Sciences Research
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Academic Research Enhancement Award (R15 Clinical Trial Required)
(PA-18-343)
National Institute on Deafness and Other Communication Disorders
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is February 25, 2018
-
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
(PA-18-344)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Nursing Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is February 16, 2018.
-
NIH Research Project Grant (Parent R01 Clinical Trial Required)
(PA-18-345)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
(PAR-18-006)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
(PAR-18-007)
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)
(PAR-18-009)
National Cancer Institute
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDDK Program Projects (P01 Clinical Trial Optional)
(PAR-18-012)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
(PAR-18-016)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
(PAR-18-017)
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional)
(PAR-18-026)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
-
Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
(PAR-18-028)
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard due date for new applications is February 5, 2018, by 5:00 PM local time of the applicant organization. The first standard due date for revision and resubmission applications is March 5, 2018, by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)
(PAR-18-029)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)
(PAR-18-030)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01- Clinical Trial Optional)
(PAR-18-039)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01 Clinical Trial Optional)
(PAR-18-042)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
(PAR-18-062)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Natural History of Disorders Identifiable by Screening of Newborns (R01 Clinical Trial Optional)
(PAR-18-090)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional)
(PAR-18-112)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
Office of Dietary Supplements
Application Receipt Date(s): For new applications: June 16, 2018 (alternating standard due dates).
For resubmission applications: November 16, 2015; July 16, 2016; March 16, 2017; November 16, 2017; and July 16, 2018 (alternating standard due dates) , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates .
-
Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional)
(PAR-18-113)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)
(PAR-18-114)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New and revision applications are due February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017; February 14, 2018; October 17, 2018; June 14, 2019.
-
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required)
(PAR-18-115)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New and revision applications are due February 1, 2018; October 1, 2018; May 31, 2019 , by 5:00 PM local time of applicant organization. Resubmission applications are due on June 20, 2017; February 14, 2018; October 17, 2018; June 14, 2019.
-
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
(PAR-18-118)
National Center for Complementary and Integrative Health
Application Receipt Date(s): New Applications: February 2, 2018; June 1, 2018; October 3, 2018; February 1, 2019; May 31, 2019; October 3, 2019; and January 31, 2020
Resubmission, Revision, and Renewal Applications: October 18, 2017, February 20, 2018, June 14, 2018, October 17, 2018, February 15, 2019, June 14, 2019, October 17, 2019, February 14, 2020
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)
(PAR-18-175)
National Institute on Aging
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply. The first standard due date for new applications is February 5, 2018, by 5:00 PM local time of the applicant organization. The first standard due date for revision and resubmission applications is March 5, 2018, by 5:00 PM local time of the applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates.
-
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)
(PAR-18-181)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional)
(PAR-18-195)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional)
(PAR-18-196)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)
(PAR-18-205)
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
(PAR-18-290)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is January 25, 2017.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
(PAR-18-296)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
-
NIA Program Project Applications (P01 Clinical Trial Optional)
(PAR-18-297)
National Institute on Aging
Application Receipt Date(s): January 25, 2018; May 25, 2018; January 25, 2019; May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed)
(PAR-18-335)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 31, 2018; July 31, 2019; July 31, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)
(PAR-18-336)
National Cancer Institute
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on .
-
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)
(PAR-18-337)
National Cancer Institute
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on.
-
NCI Research Specialist (Laboratory-based Scientist) Award (R50)
(PAR-18-341)
National Cancer Institute
Application Receipt Date(s): January 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NCI Research Specialist (Core-based Scientist) Award (R50)
(PAR-18-342)
National Cancer Institute
Application Receipt Date(s): January 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
(PAS-18-030)
National Institute on Aging
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
(PAS-18-063)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35)- Clinical Trial Not Allowed
(RFA-DE-18-011)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): January 26, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multidisciplinary Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
(RFA-DK-17-012)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
George M. O'Brien Urology Cooperative Research Centers Program (U54-Clinical Trial Optional)
(RFA-DK-17-013)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Flexible Funding Model - Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18)
(RFA-FD-18-001)
Food and Drug Administration
Application Receipt Date(s): March 1, 2018, by 11:59 PM Eastern Time.
December 1, 2018, by 11:59 PM Eastern Time.
December 1, 2019, by 11:59 PM Eastern Time.
December 1, 2020, by 11:59 PM Eastern Time.
December 1, 2021, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Mobile and Connected Health Interventions to Improve Care Continuum and Health Outcomes among Youth with HIV (R34)
(RFA-MH-18-605)
National Institute of Mental Health
National Institute on Drug Abuse
Application Receipt Date(s): January 9, 2018, by 5:00 PM local time of applicant organization. All types of S applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mobile and Connected Health Interventions to Improve Care Continuum and Health Outcomes among Youth with HIV (R01)
(RFA-MH-18-606)
National Institute of Mental Health
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 9, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.